New possibilities for targeted antiviral therapy for COVID-19. Results of a multi center clinical study of the efficacy and safety of using the drug Areplivir

Infectious diseases: News, Opinions, Training (2020) - Comments
doi: 10.33029/2305-3496-2020-9-3-16-29 issn: 2305-3496 issn: 2658-7394

L.A. Balykova, M.V. Granovskaya, K.Y. Zaslavskaya, E.N. Simakina, A.S. Agaf'ina, A.Y. Ivanova, K.B. Kolontarev, D.Y. Pushkar